Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
We are delighted to announce the finalists for the 2017 Clinical and Research Excellence Awards:
Best Patient Centric Clinical Trial
Braeburn Pharmaceuticals, Long-Term Safety Study of Buprenorphine (CAM2038) in Adult Outpatients with Opioid Use Disorder
CK Aspire, Domiciliary Service on behalf of the Salford Lung Study (SLS) sponsored by GlaxoSmithKline (GSK)
Janssen Research & Development, A Study to Evaluate the Safety and Clinical Response of Subretinal Administration of CNTO 2476 (Palucorcel) in Participants with Geographic Atrophy (PRELUDE)
PPD, CRADLE
Don’t forget to book your place to attend.
Don’t forget to book your place to attend.
Don’t forget to book your place to attend.
Don’t forget to book your place to attend.
Don’t forget to book your place to attend.
Don’t forget to book your place to attend.
Don’t forget to book your place to attend.
Most Successful Early Phase Trial (Preclinical & Phase I)
Nektar, NKTR-214 in Subjects with Locally Advanced or Metastatic Solid Tumor Malignancies
Onxeo, A first-in-human Phase I clinical trial of AsiDNA in patients with metastatic melanoma
Tocagen, Study of a Retroviral Replicating Vector to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor
Don’t forget to book your place to attend.
Don’t forget to book your place to attend.
Don’t forget to book your place to attend.
Lifetime Achievement Award
To be announced on the evening.
Winners will be announced at the awards ceremony and dinner on 5 April, at the State Room in Boston.
Don’t forget to book your place to attend.
Good luck to all of our finalists!
In Vivo: strategic insights for life sciences decision-maker...
Pharma Intelligence offers a wealth of pharmaceutical industry news and strategic insight into the healthcare & biotechnology markets from around the world. Working in an interconnected global network, our 65 journalists and over 300 in-house analysts supply comprehensive analysis and reports.
Scrip: industry news and insights
The Swiss major's pharma chief tells Scrip that its gene therapy for SMA offers much more than Biogen's Spinraza for both patients and payers, noting that the company is ready with alternative payment models for the pricey treatment as soon as approvals for Zolgensma are granted.
Topics Business strategies Drug approval Drug development landscape Drug review
Scrip: industry news and insights
By Emily Hayes
In second Phase III diabetes study to report, oral GLP-1 agonist semaglutide misses some weight loss goals when compared with Boehringer/Lilly's SGLT-2 inhibitor Jardiance.
Request a Demo
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
How can we help you?
Our team is always happy to hear from you. Please call us at:
Pharma Report Store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
To build and maintain gold-standard, next generation R&D intelligence tools, Sitetrove, Trialtrove, Pharmaprojects, and Trialpredict have been undergoing a major program of investment. In addition to the many new and exciting changes on the horizon, the robust and reliable Citeline tools that you use to inform your business decisions will formally join Informa’s Pharma Intelligence family of brands.
The industry’s most trusted drug development database, Citeline's Pharmaprojects has been covering pharma R&D across global markets for 35+ years. With 68,000+ drug profiles including 15,000 drugs in active development, it’s the go-to resource for preclinical, clinical, and pipeline coverage, and lifecycle management tracking.
Trialtrove is the go-to resource for clinical trial research. Easily track your competitors' clinical R&D activity with expert insights and continually monitored trials.
Looking for more products Product Finder
